RESUMEN
Secondary metabolites derived from hydroquinone are quite rare in nature despite the original simplicity of its structure, especially when compared to other derivatives with which it shares biosynthetic pathways. However, its presence in a prenylated form is somewhat relevant, especially in the marine environment, where it is found in different algae and invertebrates. Sometimes, more complex molecules have also been identified, as in the case of polycyclic diterpenes, such as those possessing an abietane skeleton. In every case, the presence of the dihydroxy group in the para position gives them antioxidant capacity, through its transformation into para-quinones.This review focuses on natural hydroquinones with antioxidant properties referenced in the last fifteen years. This activity, which has been generally demonstrated in vitro, should lead to relevant pharmacological properties, through its interaction with enzymes, transcription factors and other proteins, which may be particularly relevant for the prevention of degenerative diseases of the central nervous system, or also in cancer and metabolic or immune diseases. As a conclusion, this review has updated the pharmacological potential of hydroquinone derivatives, despite the fact that only a small number of molecules are known as active principles in established medicinal plants. The highlights of the present review are as follows: (a) sesquiterpenoid zonarol and analogs, whose activity is based on the stimulation of the Nrf2/ARE pathway, have a neuroprotective effect; (b) the research on pestalotioquinol and analogs (aromatic ene-ynes) in the pharmacology of atherosclerosis is of great value, due to their agonistic interaction with LXRα; and (c) prenylhydroquinones with a selective effect on tyrosine nitration or protein carbonylation may be of interest in the control of post-translational protein modifications, which usually appear in chronic inflammatory diseases.
RESUMEN
One of the best consolidated paradigms in vascular pharmacology is that an uncontrolled excess of oxidizing chemical species causes tissue damage and loss of function in the endothelial and subendothelial layers. The fact that high-density lipoproteins play an important role in preventing such an imbalance is integrated into that concept, for which the expression and activity of paraoxonases is certainly crucial. The term paraoxonase (aryldialkyl phosphatase, EC 3.1.8.1) encompasses at least three distinct isoforms, with a wide variation in substrate affinity, cell and fluid localization, and biased expression of polymorphism. The purpose of this review is to determine the interactions that paraoxonase 1 has with nitric oxide synthase, its reaction product, nitric oxide (nitrogen monoxide, NO), and its derived reactive species generated in an oxidative medium, with a special focus on its pathological implications.
RESUMEN
Atherosclerosis is one of the leading causes of death in Western countries, with high-density lipoproteins (HDL) playing an important protective role due to their ability to inhibit oxidation of low-density lipoproteins (LDL), thus relieving vascular subendothelial damage. One of the proteins constituting HDL particles is paraoxonase-1 (PON1), an enzyme able to hydrolyze aryl esters, lactones, and organophosphates. Other closely related paraoxonases are designated as PON2, which is a protein localized inside many different kinds of cells, and PON3, not only present in HDL but also in mitochondria and endoplasmic reticulum, as well. Given that the amount and the activity of PON1 in human serum are significantly lower in people suffering from cardiovascular diseases, enhancing both parameters might contribute to their treatment and prevention. One of the physiologically interesting substrates for the abovementioned hydrolytic cleavage is homocysteine thiolactone (HTL), an atherothrombotic active form of homocysteine. Although it was therefore postulated that PON1 would participate in preventing the HTL-mediated lipid peroxidation, some attention is recently paid to other enzymes, like biphenyl hydrolase-like protein, that seem to more selectively involved in lowering this risk factor. The aim of this paper is to elucidate the role of paraoxonases, especially PON1, by reviewing the latest studies in order to understand both its physiological role and modulation by drugs, nutrients, and plant extracts.
Asunto(s)
Arildialquilfosfatasa/metabolismo , Animales , Antiinflamatorios/farmacología , Productos Biológicos/farmacología , Fármacos Cardiovasculares/farmacología , Hormonas/farmacología , Humanos , Hipolipemiantes/farmacología , Estilo de VidaRESUMEN
Betulinic acid is a naturally occurring pentacyclic lupane-type triterpenoid usually isolated from birch trees, but present in many other botanical sources. It is found in different plant organs, both as a free aglycon and as glycosyl derivatives. A wide range of pharmacological activities has been described for this triterpenoid, including antiviral and antitumor effects. In addition, several other interesting properties have been identified in the fields of immunity and metabolism, namely antidiabetic, antihyperlipidemic, and anti-inflammatory activities. Taken together, these latter three properties make betulinic acid a highly interesting prospect for treating metabolic syndrome. The present review focuses on the therapeutic potential of this agent, along with several of its semisynthetic derivatives, which could open new frontiers in the use of natural product-based medicines.
Asunto(s)
Triterpenos/farmacología , Animales , Antiinfecciosos/farmacología , Antiinflamatorios/farmacología , Antineoplásicos/farmacología , Antivirales/farmacología , Citotoxinas/farmacología , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Dislipidemias/tratamiento farmacológico , Humanos , Hipoglucemiantes/uso terapéutico , Hipolipemiantes/farmacología , Inflamación/tratamiento farmacológico , Síndrome Metabólico/tratamiento farmacológico , Triterpenos Pentacíclicos , Triterpenos/química , Triterpenos/uso terapéutico , Ácido BetulínicoRESUMEN
Apocynin has been widely used as an inhibitor of the nicotinamide adenine dinucleotide phosphate oxidase (NADPH-oxidase) system and shows promise as an anti-inflammatory drug. Diapocynin, the dimeric product generated by the oxidation of apocynin in the presence of myeloperoxidase (MPO), is supposed to be its active form. In this study, diapocynin has been chemically synthesized and its activity on several inflammatory mediators in LPS-stimulated RAW 264.7 macrophages and its anti-inflammatory effect on ulcerative colitis induced by dextran sodium sulfate (DSS) in mice analyzed. We found that diapocynin showed higher inhibitory activity than apocynin. The dimer reduced ROS production, TNF-α, IL-6, and IL-1ß levels and inhibited iNOS and COX-2 expression as well as decreased NO and PGE2 production induced in LPS-stimulated RAW 264.7 cells. The anti-inflammatory molecular mechanism of diapocynin was associated with the suppression of NF-κB activation. However, these results were not paralleled by in vivo studies. Oral administration of apocynin and diapocynin (100 mg/kg) three times a week exhibited similar protections against experimental inflammatory bowel disease induced by DSS; therefore, apocynin should not be considered a prodrug. However, it should be taken into account that the dimer is more potent because its dose (0.3 mmol/kg) is half that of apocynin.
Asunto(s)
Acetofenonas/administración & dosificación , Compuestos de Bifenilo/administración & dosificación , Colitis/tratamiento farmacológico , Acetofenonas/química , Animales , Compuestos de Bifenilo/química , Colitis/genética , Colitis/inmunología , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/inmunología , Dimerización , Humanos , Interleucina-1beta/genética , Interleucina-1beta/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Estructura Molecular , FN-kappa B/genética , FN-kappa B/inmunología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
The traditional medicines of Asia and Europe have long used various Rhodiola species, which are endemic to the subarctic areas of the northern hemisphere, as tonic, adaptogen, antidepressant, and anti-inflammatory drugs. In order to establish the therapeutic uses of these plants in modern medicine, the pharmacological effects of Rhodiola sp. have been widely studied. Indeed, the most amply researched species, Rhodiola rosea, has been shown to possess antioxidant, adaptogenic, antistress, antimicrobial, immunomodulatory, angiomodulatory, and antitumoral effects. Salidroside (p-hydroxyphenethyl-ß-D-glucoside), a major compound in Rhodiola, seems to be responsible for many of the effects observed with Rhodiola extracts.The aim of this paper is to review the pharmacological effects not only of various Rhodiola species, mainly R. rosea along with Rhodiola imbricata, Rhodiola algida, and Rhodiola crenulata, but also of salidroside, focusing especially on its antioxidant, immunomodulatory, antitumoral, and antiproliferative activities, as well as to describe their therapeutic significance in disease management. Although previous pharmacological studies have established a scientific basis for possible therapeutic uses of Rhodiola extracts and salidroside, high-quality, randomized, controlled clinical trials are still needed.
Asunto(s)
Extractos Vegetales/farmacología , Rhodiola/química , Animales , Antineoplásicos Fitogénicos/farmacología , Proliferación Celular/efectos de los fármacos , Glucósidos/uso terapéutico , Humanos , Factores Inmunológicos/farmacología , Fenoles/uso terapéutico , Especificidad de la EspecieRESUMEN
Three phenolic antioxidant and anti-inflammatory compounds: 7-methylaromadendrin, isoprenylhydroquinone glucoside, and 3.5-dicaffeoylquinic acid methyl ester, all isolated from Western Mediterranean Asteraceae species, have been studied for their inhibitory activity against protein carbonylation, a harmful post-translational modification of peptide chains associated with degenerative diseases. All compounds have proven to be effective, with 50% inhibitory concentration (IC50) values in the micromolar range, against bovine serum albumin carbonylation caused by hypochlorite, peroxynitrite, and phorbol ester-induced leukocyte oxidative burst.
Asunto(s)
Asteraceae/química , Ácido Clorogénico/análogos & derivados , Flavonoides/farmacología , Glucósidos/farmacología , Hidroquinonas/farmacología , Fenoles/farmacología , Carbonilación Proteica/efectos de los fármacos , Antioxidantes/farmacología , Sistema Libre de Células , Ácido Clorogénico/farmacología , Flavanonas/farmacología , Humanos , Ácido Hipocloroso/farmacología , Concentración 50 Inhibidora , Neutrófilos/metabolismo , Ácido Peroxinitroso/farmacología , Ésteres del Forbol/farmacología , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Estallido Respiratorio , Albúmina Sérica Bovina/metabolismoRESUMEN
2-isoprenylhydroquinone-1-glucoside (1), 3,5-dicaffeoylquinic acid (2), and 3,5-dicaffeoylquinic acid methyl ester (3), isolated from Phagnalon rupestre, improved the contact hypersensitivity response to 2,4,6-trinitrochlorobenzene in mice. These phenolics reduced ear swelling and IL-1ß content by 50% 24 h after challenge; in addition, 2 inhibited tumor necrosis factor-α by 53%. All three compounds also reduced interleukin-2 content by 50% 72 h after challenge. Both 2 and 3 inhibited metalloproteinase-9 levels in the skin lesions by 66% and 41%, respectively, and lowered cyclooxygenase-2 expression by 44% and 49%, respectively, at 24 h. Moreover, 2 was effective against atopic dermatitis induced by repeated application of 2,4,6-trinitrochlorobenzene; it attenuated edema by over 40% from day 7 and inhibited inflammatory cell infiltration by 44% at day 22. In addition, 1-3 reduced metalloproteinase-9 expression in a dose-dependent manner in macrophages RAW 264.7 stimulated with lipopolysaccharide. Thus, compounds 2 and 3 were found to exhibit a greater activity against contact hypersensitivity than 1.
Asunto(s)
Dermatitis por Contacto/patología , Fenoles/aislamiento & purificación , Fenoles/farmacología , Cloruro de Picrilo/farmacología , Animales , Inhibidores de la Ciclooxigenasa 2/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Oído/patología , Edema/inducido químicamente , Interleucina-1beta/análisis , Interleucina-1beta/metabolismo , Interleucina-2/análisis , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Ratones , Fenoles/química , Piel/efectos de los fármacos , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Cucurbitacin R is known to exhibit an anti-inflammatory effect in different experimental models of inflammation. In this article, we outline the effect of cucurbitacin R on T lymphocyte proliferation, cytokine production, and nuclear factor activation, as well as its influence on various experimental models of delayed-type hypersensitivity (DTH) in mice. Cucurbitacin R reduced the proliferation of phytohemagglutinin A-stimulated human T lymphocytes (IC(50), 18 microM), modifying the cell cycle, as well as the production of cytokines [interleukin (IL)-2, IL-4, IL-10, and especially interferon-gamma] and the induction of the principal cyclins implicated in the cell cycle (A(1), B(1), D(2), and E). These effects are brought on by a novel, selective inhibition of nuclear factor AT (NFAT) by cucurbitacin R, with no concomitant effect on other transcription factors such as activator protein-1. In addition, we tested the in vivo effects of cucurbitacin R in three experimental models of DTH, as well as its effects on T lymphocyte proliferation, the cell cycle, cytokines, and cyclins. Although cucurbitacin R was found to reduce the inflammatory response brought on by both oxazolone and dinitrofluorobenzene, its activity was even more pronounced against sheep red blood cell-induced edema in mouse paws, with a clear reduction in the production of IL-1beta, IL-4, and tumor necrosis factor alpha in the inflamed paw. In conclusion, cucurbitacin R has the potential to be a new immunosuppressive agent with antiproliferative effects through the inhibition of the NFAT with anti-inflammatory activity in DTH reactions.
Asunto(s)
Proliferación Celular/efectos de los fármacos , Citocinas/metabolismo , Hipersensibilidad a las Drogas/tratamiento farmacológico , Hipersensibilidad Tardía/prevención & control , Factores de Transcripción NFATC/antagonistas & inhibidores , Triterpenos/farmacología , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Ciclo Celular/efectos de los fármacos , Ciclinas/metabolismo , Dinitrofluorobenceno/farmacología , Oído/patología , Femenino , Pie/patología , Humanos , Hipersensibilidad Tardía/inducido químicamente , Hipersensibilidad Tardía/patología , Péptidos y Proteínas de Señalización Intracelular/efectos de los fármacos , Células Jurkat , Ratones , Factores de Transcripción NFATC/metabolismo , Oxazolona/farmacología , Linfocitos T/efectos de los fármacos , Linfocitos T/metabolismo , Triterpenos/uso terapéuticoRESUMEN
Esta revisión trata esencialmente sobre los diterpenos antiinflamatorios procedentes de especies de Labiadas. Se estudian las publicaciones posteriores a 2002 referentes a los cuatro tipos estructurales más importantes en esa familia: labdano, abietano, pimarano y kaurano. Además se incluyen algunas moléculas interesantes obtenidas de especies de diferente origen taxonómico. De entre los mecanismos implicados destaca la inhibición del metabolismo del ácido araquidónico a través de ciclooxigenasas y lipoxigenasas, así como el freno a la producción de NO o citocinas. Adicionalmente se ha descrito para algunos principios el aumento de la expresión de hemo-oxigenasa 1. Algunos de los géneros botánicos mejor representados son Lavandula, Isodon, Rosmarinus y Sideritis (AU)
This review is devoted to the antiinflammatory diterpenoids obtained from species of Labiatae. Basically, we study the post-2002 publications concerning the four major structural types in the family: labdane, abietane, pimarane and kaurane. Certain interesting diterpenes derived from plants of different taxonomic origin are also reported. Among the mechanisms involved in the pharmacological effect, we should highlight the inhibition of arachidonic acid metabolism through cyclo-oxygenases and lipoxygenases, and the decrease in the production of NO or cytokines. Additionally, some principles are described as enhancers of the expression of heme oxygenase 1. Some of the botanical genera best represented are Lavandula, Isodon, Rosmarinus or Sideritis (AU)
Asunto(s)
Abietanos/inmunología , Abietanos/uso terapéutico , Diterpenos de Tipo Kaurano/inmunología , Diterpenos de Tipo Kaurano/uso terapéutico , Diterpenos/inmunología , Diterpenos/uso terapéutico , Ácido Araquidónico/inmunología , Ácido Araquidónico/metabolismo , Lavandula/inmunología , Lavandula/metabolismo , Inhibidores de la Ciclooxigenasa/uso terapéutico , /uso terapéutico , Isodon , Isodon/inmunología , Rosmarinus/inmunología , Rosmarinus/metabolismoRESUMEN
Plant phenolic antioxidants, among them catechins and hydroxycinnamoyl conjugates, constitute a well defined class of inhibitors of reactive nitrogen species (RNS). To gain deeper insight in this field, we examined the effects of 3,5-di-O-caffeoylquinic acid (DCA), its methyl ester (DCE) and epigallocatechin gallate (EGCG) in nitrative and oxidative processes. These compounds were found to be strong inhibitors of the nitration of tyrosine residues induced by ONOO- in bovine seroalbumin, with their IC50 values (10-40 microM) notably decreasing in the presence of bicarbonate. When studied on the intracellular protein tyrosine nitration induced by ONOO- in cultured murine fibroblasts as well as that induced by phorbol ester (PMA) in nitrite-supplemented human neutrophils, all three phenolics were also effective (100% and over 75% inhibition for fibroblasts and neutrophils, respectively, at 25 microM). This ability seems to be due to a direct interaction with ONOO- or with the species generated by leukocytes. The possible interference with the production of NO was also studied: both DCA and EGCG inhibited nitrite production in LPS-stimulated macrophages by 24% and 40%, respectively, and the expression of nitric oxide synthase-2 (NOS-2), as well. DCA and EGCG reduced by 52% and 59%, respectively, the NF-kappaB transcriptional activity. In contrast, DCE did not show any effect. The assayed phenolics exert varying degrees of protection against the chemical modifications induced by RNS depending not only on the hydroxyl pattern, but also on the presence of bicarbonate.
Asunto(s)
Ácido Peroxinitroso/farmacología , Ácido Quínico/análogos & derivados , Especies de Nitrógeno Reactivo/antagonistas & inhibidores , Animales , Bicarbonatos/química , Catequina/análogos & derivados , Catequina/farmacología , Bovinos , Fibroblastos/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Ratones , Neutrófilos/efectos de los fármacos , Nitratos/química , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/genética , Nitritos/antagonistas & inhibidores , Oxidación-Reducción , Ácido Quínico/farmacología , Albúmina Sérica Bovina/química , Estimulación Química , Acetato de Tetradecanoilforbol/farmacología , Tirosina/químicaRESUMEN
The anti-inflammatory properties of three flavanones isolated from Inula viscosa, sakuranetin, 7-O-methylaromadendrin, and 3-acetyl-7-O-methylaromadendrin, have been tested both in vitro and in vivo. Acute inflammation in vivo was induced by means of topical application of 12-O-tetradecanoylphorbol 13-acetate (TPA) to mouse ears or by subcutaneous injection of phospholipase A(2) (PLA(2)) into mouse paws. The test compounds were evaluated in vitro for their effect on both the metabolism of arachidonic acid and on the release and/or activity of enzymes involved in the inflammatory response such as elastase, myeloperoxidase (MPO), and protein kinase C (PKC). The most active compounds in vivo against PLA(2)-induced paw oedema were 7-O-methylaromadendrin (ED(50)=8 mg/kg) and sakuranetin (ED(50)=18 mg/kg). In contrast, the most potent compound against TPA-induced ear oedema was 3-acetyl-7-O-methylaromadendrin (ED(50)=185 microg/ear), followed by sakuranetin (ED(50)=205 microg/ear). In vitro, the latter compound was the most potent inhibitor of leukotriene (LT) B(4) production by peritoneal rat neutrophils (IC(50)=9 microM) and it was also the only compound that directly inhibited the activity of 5-lipoxygenase (5-LOX). 3-Acetyl-7-O-methylaromadendrin also inhibited LTB(4) production (IC(50)=15 microM), but had no effect on 5-LOX activity. The only flavanone that inhibited the secretory PLA(2) activity in vitro was 7-O-methylaromadendrin. This finding may partly explain the anti-inflammatory effect observed in vivo, although other mechanisms such as the inhibition of histamine release by mast cells may also be implicated. Sakuranetin at 100 microM was found to inhibit elastase release, although this result is partly due to direct inhibition of the enzyme itself. At the same concentration, 7-O-methylaromadendrin only affected the enzyme release. Finally, none of the flavanones exhibited any effect on MPO or PKC activities. Taken together, these findings indicate that sakuranetin may be a selective inhibitor of 5-LOX.
Asunto(s)
Antiinflamatorios no Esteroideos , Ácido Araquidónico/metabolismo , Flavonoles/farmacología , Inflamación/prevención & control , Inula/química , Animales , Araquidonato 5-Lipooxigenasa/metabolismo , Supervivencia Celular/efectos de los fármacos , Dinoprostona/metabolismo , Edema/inducido químicamente , Edema/enzimología , Edema/prevención & control , Femenino , Flavonoles/aislamiento & purificación , Liberación de Histamina/efectos de los fármacos , Humanos , Técnicas In Vitro , Inflamación/patología , Elastasa de Leucocito/metabolismo , Leucotrieno B4/biosíntesis , Ratones , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Peroxidasa/metabolismo , Fosfolipasas A/metabolismo , Proteína Quinasa C/metabolismo , Ratas , Acetato de TetradecanoilforbolRESUMEN
We have studied the effects of dihydrocucurbitacin B, a triterpene isolated from Cayaponia tayuya roots, on different models of delayed type hypersensitivity (DTH) in mice, as well as on T-lymphocyte proliferation and the mediators involved. In experiments with mice, dihydrocucurbitacin B inhibited the inflammatory reactions induced by oxazolone, dinitrofluorobenzene, and sheep red blood cells, reducing both the edema and cell infiltration. Moreover, the analysis of inflamed tissues showed that dihydrocucurbitacin B reduced the presence of the most relevant cytokines implicated in these processes, including interleukin-1 beta, interleukin-4, and tumor necrosis factor-alpha. Dihydrocucurbitacin B was also found to inhibit the proliferation of phytohemagglutinin-stimulated human T lymphocytes (IC(50) = 1.48 microM), halting the cell cycle in the G(0) phase. In addition, the triterpene reduced the production of interleukin-2, interleukin-4, interleukin-10, and interferon-gamma in human T lymphocytes, and it hampered the induction of the principal cyclins involved in the cell cycle, including A(1), B(1), D(2), and E(1). Finally, dihydrocucurbitacin B was found to exert a selective inhibition on the nuclear factor of activated T cells (NFAT) in human lymphocytes without affecting the calcium influx. Taken together, these results suggest that dihydrocucurbitacin B curbs DTH reactions by inhibiting NFAT, which in turn suppresses the proliferation of the most relevant cells involved in DTH reactions, namely the T cells.
Asunto(s)
Hipersensibilidad Tardía/tratamiento farmacológico , Activación de Linfocitos/efectos de los fármacos , Triterpenos/farmacología , Animales , Ciclinas/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/efectos de los fármacos , Modelos Animales de Enfermedad , Inflamación/prevención & control , Ratones , Factores de Transcripción NFATC/antagonistas & inhibidores , Fase de Descanso del Ciclo CelularRESUMEN
This work concerns the pharmacological activity of inuviscolide, a sesquiterpenoid from Inula viscosa. It exerts inhibitory effects on elastase, cyclooxygenase 1 and secretory phospholipase A(2). Furthermore, it reduces the skin leukocyte infiltration in a murine model of dermatitis induced by repeated application of 12-O-tetradecanoylphorbol 13-acetate.
Asunto(s)
Inhibidores Enzimáticos/farmacología , Inula , Fitoterapia , Sesquiterpenos/farmacología , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Dermatitis/tratamiento farmacológico , Dermatitis/etiología , Inhibidores Enzimáticos/administración & dosificación , Inhibidores Enzimáticos/uso terapéutico , Humanos , Lactonas/administración & dosificación , Lactonas/farmacología , Lactonas/uso terapéutico , Leucocitos/enzimología , Ratones , Elastasa Pancreática/antagonistas & inhibidores , Elastasa Pancreática/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Sesquiterpenos/administración & dosificación , Sesquiterpenos/uso terapéutico , Acetato de TetradecanoilforbolRESUMEN
Two flavonoids, gnaphaliin and tiliroside, isolated from Helichrysum italicum, were studied in vitro for their capacity to inhibit Cu(2+)-induced human low density lipoprotein (LDL) and diluted plasma oxidation. LDL oxidation was monitored by conjugated diene, thiobarbituric acid-reactive substances (TBARS) formation and electrophoretic mobility on agarose gel. Gnaphaliin and tiliroside increased the lag-phase for diene conjugate production in a dose-dependent manner. The reduction of TBARS production confirmed the antioxidant activity of gnaphaliin and tiliroside with 50% inhibitory concentration (IC(50)) values of 8.0+/-3.9 microM and 7.0+/-2.6 microM respectively. Furthermore, the flavonoids negated the Cu(2+)-induced increase in electrophoretic mobility of LDL. Antioxidant activity of gnaphaliin and tiliroside was significantly different when diluted plasma was oxidised by adding 1 mM CuSO(4). Although both flavonoids again reduced the TBARS production, tiliroside showed higher activity than gnaphaliin (IC(50)=10.6+/-2.5 microM vs. IC(50)>50 microM). In conclusion, tiliroside and gnaphaliin are antioxidants against in vitro Cu(2+)-induced LDL oxidation in the same order of magnitude compared to that of the reference drug, probucol.
Asunto(s)
Benzopiranos/farmacología , LDL-Colesterol/efectos de los fármacos , Flavonas/farmacología , Helichrysum , Peroxidación de Lípido/efectos de los fármacos , Lipoproteínas LDL/farmacología , Fitoterapia , Benzopiranos/administración & dosificación , Benzopiranos/uso terapéutico , Sulfato de Cobre/química , Flavonas/administración & dosificación , Flavonas/uso terapéutico , Flavonoides , Humanos , Concentración 50 Inhibidora , Lipoproteínas LDL/administración & dosificación , Lipoproteínas LDL/uso terapéutico , Componentes Aéreos de las Plantas , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Sustancias Reactivas al Ácido Tiobarbitúrico/químicaRESUMEN
The present study was designed to optimize the experimental conditions that govern the heme-catalyzed nitration of protein tyrosine residues by nitrite, and, within this framework, to study the effects of 3,5-dicaffeoylquinic acid and its methyl ester, both of which have been previously reported to be antioxidants and inhibitors of leukocyte functions. Although the presence of hydrogen peroxide is essential in cell-free systems, an excess of this compound was found to be detrimental, so much so that an increase in hemin concentration actually resulted in an inverse effect on the reaction, depending on the levels of fixed hydrogen peroxide. Unlike previous reports on nitrite-induced albumin tyrosine nitration, the optimal pH here was found to be 7.0. The two caffeoyl conjugates tested were found to be effective inhibitors of protein nitration, with IC50 values ranging from 20 - 30 microM, regardless of the presence of bicarbonate. For the inhibition of myeloperoxidase-catalyzed protein nitration by human polymorphonuclear leukocytes stimulated by phorbol ester, the potencies obtained were up to two times higher. This is the first time that caffeoylquinic esters have been reported as inhibitors of heme-based protein nitration.
Asunto(s)
Asteraceae , Nitratos/química , Fitoterapia , Tirosina/análogos & derivados , Catálisis , Ácidos Cumáricos/química , Hemo/química , Hemoproteínas/química , Humanos , Peróxido de Hidrógeno/química , Concentración de Iones de Hidrógeno , Concentración 50 Inhibidora , Leucocitos , Tirosina/antagonistas & inhibidores , Tirosina/químicaRESUMEN
We have studied scrovalentinoside, an iridoid with anti-inflammatory properties isolated from Scrophularia auriculata ssp. pseudoauriculata, as an anti-inflammatory agent in different experimental models of delayed-type hypersensitivity. We found that scrovalentinoside reduced the edema induced by oxazolone at 0.5 mg/ear and sheep red blood cells at 10 mg/kg. The observed effect occurred during the last phase or inflammatory response; during the earlier phase or induction of the delayed-type hypersensitivity reaction, no significant activity was noted. Thus, scrovalentinoside reduced both the edema and cell infiltration in vivo and reduced lymphocyte proliferation in vitro, affecting the cycle principally during the first 48 h. Whereas cells stimulated with phytohemagglutinin changed from the G(0)/G(1) phase to the S and G(2)/M phases, when these same cells were treated with scrovalentinoside (100 microM), they remained in the G(0)/G(1) phase. Finally, scrovalentinoside inhibited the production of the pro-inflammatory mediators' TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, LTB(4), and NO, but had no effect on the production of the anti-inflammatory cytokine IL-10.
Asunto(s)
Antiinflamatorios/farmacología , Edema/tratamiento farmacológico , Glicósidos/farmacología , Hipersensibilidad Tardía/tratamiento farmacológico , Iridoides/farmacología , Scrophularia/química , Animales , Western Blotting , Ciclo Celular/efectos de los fármacos , Ciclo Celular/inmunología , Proliferación Celular , Modelos Animales de Enfermedad , Edema/inducido químicamente , Femenino , Humanos , Hipersensibilidad Tardía/inducido químicamente , Hipersensibilidad Tardía/inmunología , Mediadores de Inflamación/metabolismo , Glicósidos Iridoides , Macrófagos/metabolismo , Ratones , Oxazolona , Fitohemaglutininas , Preparaciones de Plantas/química , Preparaciones de Plantas/farmacología , Plantas Medicinales , Ratas , Receptores de Glucocorticoides/efectos de los fármacos , Receptores de Glucocorticoides/inmunología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunologíaRESUMEN
Scropolioside A, an iridoid isolated from Scrophularia auriculata ssp. pseudoauriculata, showed anti-inflammatory properties against different experimental models of delayed-type hypersensitivity. This iridoid reduced the oedema induced by oxazolone by 79% (72 h) at 0.5 mg/ear while reducing that induced by sheep red blood cells by 47% (18 h), 45% (24 h) and 36% (48 h) at 10 mg/kg. In vivo it reduced both oedema formation and cell infiltration whereas in vitro it reduced the proliferation of activated T-lymphocytes (IC50 of 67.74 microM). Treatment with scropolioside A (100 microM) 18 and 24 h after phytohemagglutinin stimulation increased the number of cells arrested in the subG(0) phase whereas treatment 3 h after stimulation clearly increased the number of cells that passed to the S phase. Scropolioside A also inhibited the production of prostaglandin E2, leukotriene B4, nitric oxide, interleukin-1beta, interleukin-2, interleukin-4, tumour necrosis factor-alpha and interferon-gamma, but had no effect on the production of interleukin-10. Moreover, it modified the expression of both nitric oxide synthase-2 and cyclooxygenase-2, as well as the activation of nuclear factor-kappaB in RAW 264.7 macrophages.
Asunto(s)
Antiinflamatorios/farmacología , Glucósidos/farmacología , Piranos/farmacología , Alérgenos , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Línea Celular , Citocinas/biosíntesis , Dinoprostona/inmunología , Oído/patología , Edema/inducido químicamente , Eritrocitos/inmunología , Femenino , Humanos , Hipersensibilidad Tardía/inducido químicamente , Hipersensibilidad Tardía/tratamiento farmacológico , Hipersensibilidad Tardía/inmunología , Hipersensibilidad Tardía/patología , Leucotrieno B4/inmunología , Lipopolisacáridos , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Ratones , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Oxazolona , Elastasa Pancreática/inmunología , Ovinos , Linfocitos T/citología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunologíaRESUMEN
The nitration of tyrosine caused by peroxynitrite and other reactive nitrogen species is clearly detrimental for some physiological processes; however, its signalling role is still open to controversy. Among the natural phenolics known for their ability to oppose free tyrosine nitration, isoprenylhydroquinone glucoside is investigated due to its unusual structure, which contains a simple hydroxybenzene alkylated by a hemiterpenoid moiety. This hydroquinone was shown to be an effective inhibitor of peroxynitrite-induced protein tyrosine nitration in 3T3 fibroblasts. When tested on bovine seroalbumin nitration, however, the potency was reduced by half and the effect was almost abolished in the presence of bicarbonate. In contrast, addition of this anion had no effect on the nitrite/hydrogen peroxide/hemin system. Isoprenylhydroquinone glucoside was also active in the microM range on intra- and extracellular protein-bound tyrosine nitration by phorbol 12-myristate 13-acetate-stimulated neutrophils. The effects on nitric oxide synthase expression, interleukin-1beta and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages were quite moderate. Thus, isoprenylhydroquinone glucoside is an inhibitor of protein nitration in situ, but lacks effect on the generation of either nitric oxide or inflammatory cytokines.
Asunto(s)
Glucósidos/farmacología , Hidroquinonas/farmacología , Mediadores de Inflamación/metabolismo , Nitratos/metabolismo , Tirosina/química , Células 3T3 , Animales , Western Blotting , Supervivencia Celular , Sistema Libre de Células , Células Cultivadas , Fibroblastos/efectos de los fármacos , Hemo/farmacología , Humanos , Peróxido de Hidrógeno/farmacología , Interleucina-1beta/biosíntesis , Lipopolisacáridos/farmacología , Ratones , Neutrófilos/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Óxido Nítrico Sintasa de Tipo II/genética , Nitritos/metabolismo , Ácido Peroxinitroso/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rodaminas , Albúmina Sérica Bovina/química , Estimulación Química , Acetato de Tetradecanoilforbol/farmacología , Factor de Necrosis Tumoral alfa/biosíntesisRESUMEN
The aim of this study was to investigate the effects of cucurbitacin R on an experimental model of adjuvant-induced arthritis in rats. The treatment of arthritic rats with cucurbitacin R (1 mg/kg p.o. daily) modified the evolution of the clinical symptoms, whereas the histopathology of paws demonstrated a reduction in the signs of arthritis. Compared with the control group, radiography of the tibiotarsal joints of cucurbitacin R-treated rats showed a decrease in joint damage and soft tissue swelling of the footpad. The in vivo study of the expression of proinflammatory enzymes (nitric-oxide synthase-2 and cyclooxygenase-2) with the aid of the Western blot technique, and that of tumor necrosis factor-alpha (TNF-alpha) and prostaglandin E(2) by means of enzyme-linked immunosorbent assays demonstrated a clear decrease in both the enzymes and the mediators in paw homogenates. The analysis for prostaglandin E(2), nitric oxide, and TNF-alpha production in RAW 264.7 macrophages, as well as that for TNF-alpha in human lymphocytes, indicated a reduction of all mediators. The expression of cyclooxygenase-2 was not modified in RAW 264.7 macrophages, whereas the expression of nitric-oxide synthase-2 was clearly diminished. Moreover, cucurbitacin R was found to inhibit signal transducer and activator of transcription 3 activation in the lymphocytes of both healthy and arthritic men. These experimental data on the chronic model, together with previously reported activity on acute and subchronic experimental models, justify the anti-inflammatory activity of cucurbitacin R and provide further evidence for the therapeutic potential of a group of natural products as anti-inflammatory agents.